Dangote Group pledges to invest $2.3bn in Northern Nigeria

TWITTER
FACEBOOK
This Day | 11 May 2014
Nigerian businessman Aliko Dangote has said that he will invest $2.3bn in sugar and rice production in the north of the country.

Dangote Group pledges to invest $2.3bn in Northern Nigeria

The Dangote Group yesterday pledged to invest $2.3 billion in sugar-cane and rice production in the Northern part of the country by 2017.

The Executive Director, Dangote Group, Alhaji Mansur Ahmed, made the pledge in his speech at the Northern States Governors’ Forum (NSGF) and United States Investors’ Summit held in Abuja.

“In three to five years Dangote Group would be investing about $2.3 billion in the Northern part of the country, the current investment is low and we are prepared to upscale it,” he said, according to a News Agency of Nigeria (NAN) report.

He said the conglomerate would require about 250,000 hectares of land for sugar cane production and 130,000 hectares for rice farming.

Ahmed explained that the investment was capable of generating a total of 180,000 direct employments for the inhabitants of the region.

The Executive Director said, “The group will not be deterred by the security situation in the region. There is nothing wrong attracting foreign investors to the country.

“But I think it will work well for all of us if local investors set the pace as that would raise the confidence level of other conglomerates to do business here. So Dangote Group is prepared to lead the way for the industrialisation of the north and the country as a whole,” he said.

Ahmed explained that the region had comparative advantage in several areas, adding that it was time to rise above sentiment to improve the socio-economic status of the region.

“Northern Nigeria has comparative advantage in all fronts to feed the World with agro-allied products. The leaders of the region must continue to provide good leadership that would promote enterprise,” he added.
Original source: This Day
TWITTER
FACEBOOK
TWITTER
FACEBOOK

Post a comment

Name

Email address (optional - if you want a reply)

Comment